2019 Clinical Research Forum Top Ten | Transthyretin Cardiac Amyloidosis
2 Views
administrator
07/08/23
Transthyretin Cardiac Amyloidosis: Overlooked, Under Appreciated and Treatable, nominated by Columbia University and represented by Dr. Mathew S. Maurer, Arnold and Arlene Goldstein Professor of Cardiology. Transthyretin amyloid cardiomyopathy is an under-diagnosed and often overlooked cause of heart failure. This randomized, double blind, prospective, and international multicenter study evaluated the drug tafamidis for patients with the genetic and non-genetic forms of transthyretin amyloidosis.
-
Category
Show more
Facebook Comments
No comments found